Safety study of LUMISIGHT during breast cancer surgery
Part of Cancer, Immune system & allergy, Skin clinical trials.
This study watches for any side effects when patients receive LUMISIGHT, a dye injection that helps surgeons see cancer cells during lumpectomy (breast-conserving surgery). Researchers collect safety information to make sure the dye is safe for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with primary breast cancer (cancer that started in the breast, not spread from elsewhere)
- You are scheduled to have a lumpectomy (surgery to remove the cancer while keeping most of your breast)
- Your doctor has decided you should receive LUMISIGHT during your surgery
- You can follow the study procedures and visits as required
- You have never had a severe allergic reaction to pegulicianine (the active ingredient in LUMISIGHT)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects real-world data on how LumiSystem (a surgical imaging tool) helps surgeons see and remove breast tissue during lumpectomy procedures. You would be asked to participate if you're having this FDA-approved surgery to help doctors understand how well it works.
This trial tests a dye called Cytalux (pafolacianine) to help surgeons see cancer during lung or ovarian cancer surgery. If you are scheduled for surgery to remove lung cancer or to debulk ovarian cancer, you may be eligible.
This trial tests a dye that makes lung cancer cells glow during surgery, helping surgeons remove more of the tumor. It's for people who are already scheduled for lung cancer surgery.
This trial tests a dye called Cytalux that helps surgeons see cancer during surgery. You get the dye before surgery, and it makes cancer cells glow under a special light. This could help doctors remove more cancer.
This trial compares a new imaging method (LuminoMark) to the usual approach for finding and removing cancer in the lymph nodes under the arm during surgery. It may help doctors more precisely target and remove the affected nodes, which could improve treatment and reduce side effects.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
Hear when a new Hypersensitivity Reactions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.